Beijing Business Daily (Reporter Yao Qian) On March 13, Mingde Bio released an announcement on abnormal fluctuations in stock trading, saying that, according to the National Health and Health Commission, after research, the State Council responded to the new coronavirus The Comprehensive Team of the Joint Prevention and Control Mechanism for the Pneumonia Epidemic decided to add antigen testing as a supplement on the basis of nucleic acid testing, and organized the formulation of the “New Coronavirus Antigen Testing Application Program (Trial)”. The company’s new crown antigen detection reagent has submitted a registration application to the State Drug Administration, and the timing of obtaining the registration certificate is still uncertain.
[Source: Beijing Business Daily]
Statement : This article is reproduced for the purpose of conveying more information. If the source is incorrectly marked or infringes your legal rights, please contact the author with the ownership certificate, and we will correct or delete it in time, thank you. Email address: [email protected]